Body Composition Monitoring for Determination of the Fluid Status in Volunteers Undergoing Intravenous Fluid Therapy

NCT02296294 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Fluid Shifts
Body Fluid Compartments

Interventions

DRUG: Elo-mel® (Fresenius Kabi Austria)
DEVICE: Body Composition Monitoring

Sponsor

Medical University of Vienna